NHS to Offer Personalised ‘Living Drug’ for Aggressive Leukaemia in England
NHS England will offer obe-cel, a personalised CAR-T ‘living drug’, to adults with aggressive B‑cell ALL after trials put 77% of patients into remission.
NHS England will offer obe-cel, a personalised CAR-T ‘living drug’, to adults with aggressive B‑cell ALL after trials put 77% of patients into remission.
University Hospitals Sussex fined £200k after 16-year-old Ellame Ford-Dunn died having absconded from Worthing hospital, as parents demand mental health reform.
Nearly 40 Labour MPs urge Rachel Reeves to drop plans for privately financed NHS centres, warning 'PFI 2.0' would breach the party's public funding pledge.